Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

[Clinical features of familial non-medullary thyroid cancer patients].

Zhang X, An C, Wan H, Zhang Z, Liu W, Li Z, Xu Z, Tang P.

Zhonghua Zhong Liu Za Zhi. 2014 Jan;36(1):69-73. Chinese.

PMID:
24685091
2.

[Clinical and biological features of familial nonmedullary thyroid carcinoma].

Gao J, Yu Y, Li X, Zhao J, Zhao C, Zhao J, Liu Y, Li Y, Gao M.

Zhonghua Zhong Liu Za Zhi. 2014 Mar;36(3):202-6. Chinese.

PMID:
24785281
3.

Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity.

Capezzone M, Marchisotta S, Cantara S, Busonero G, Brilli L, Pazaitou-Panayiotou K, Carli AF, Caruso G, Toti P, Capitani S, Pammolli A, Pacini F.

Endocr Relat Cancer. 2008 Dec;15(4):1075-81. doi: 10.1677/ERC-08-0080. Epub 2008 Oct 2.

4.

The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases.

Park YJ, Ahn HY, Choi HS, Kim KW, Park DJ, Cho BY.

Thyroid. 2012 Apr;22(4):356-62. doi: 10.1089/thy.2011.0163. Epub 2012 Jan 26.

5.

Clinicopathologic characteristics of familial versus sporadic papillary thyroid carcinoma.

Jiwang L, Zhendong L, Shuchun L, Bo H, Yanguo L.

Acta Otorhinolaryngol Ital. 2015 Oct;35(4):234-42.

6.

Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population.

Uchino S, Noguchi S, Kawamoto H, Yamashita H, Watanabe S, Yamashita H, Shuto S.

World J Surg. 2002 Aug;26(8):897-902. Epub 2002 Apr 30.

PMID:
11965446
7.

Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer.

Moses W, Weng J, Kebebew E.

Thyroid. 2011 Apr;21(4):367-71. doi: 10.1089/thy.2010.0256. Epub 2010 Dec 29.

8.

Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation.

Hillenbrand A, Varhaug JE, Brauckhoff M, Pandev R, Haufe S, Dotzenrath C, Köberle R, Hoffmann R, Klein G, Kadmon M, Negele T, Hagieva T, Henne-Bruns D, Luster M, Weber T.

Langenbecks Arch Surg. 2010 Sep;395(7):851-8. doi: 10.1007/s00423-010-0696-0. Epub 2010 Aug 5.

PMID:
20683623
9.

Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series.

Alsanea O, Wada N, Ain K, Wong M, Taylor K, Ituarte PH, Treseler PA, Weier HU, Freimer N, Siperstein AE, Duh QY, Takami H, Clark OH.

Surgery. 2000 Dec;128(6):1043-50;discussion 1050-1.

PMID:
11114641
10.

Detection of asymptomatic differentiated thyroid carcinoma by neck ultrasonographic screening for familial nonmedullary thyroid carcinoma.

Uchino S, Noguchi S, Yamashita H, Murakami T, Watanabe S, Ogawa T, Tsuno A, Shuto S.

World J Surg. 2004 Nov;28(11):1099-102.

PMID:
15490050
11.

In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.

Mazeh H, Benavidez J, Poehls JL, Youngwirth L, Chen H, Sippel RS.

Thyroid. 2012 Jan;22(1):3-8. doi: 10.1089/thy.2011.0192. Epub 2011 Dec 2.

PMID:
22136209
12.

Reliability of fine-needle aspiration in patients with familial nonmedullary thyroid cancer.

Vriens MR, Sabanci U, Epstein HD, Ngai S, Duh QY, Siperstein AE, Clark OH.

Thyroid. 1999 Oct;9(10):1011-6.

PMID:
10560956
13.

[Clinical analysis of lymphocytic thyroiditis coexistent with papillary thyroid carcinoma].

Wang SX, She ZQ, An CM, Zhang XW, Li ZJ, Tang PZ.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Apr 7;51(4):277-81. doi: 10.3760/cma.j.issn.1673-0860.2016.04.007. Chinese.

PMID:
27095720
14.

Clinicopathologic features of familial nonmedullary thyroid carcinoma.

Fan YF, Zhang B, Yang X, Shang ZH, Liu HF, Xie Y, Liu YW, Gao WS, Wu Q, Li XY.

Chin Med J (Engl). 2015 Apr 20;128(8):1037-41. doi: 10.4103/0366-6999.155075.

15.
16.

Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma.

Lee YM, Yoon JH, Yi O, Sung TY, Chung KW, Kim WB, Hong SJ.

J Surg Oncol. 2014 Feb;109(2):168-73. doi: 10.1002/jso.23447. Epub 2013 Oct 16.

PMID:
24132694
17.

Clinicopathological features and prognosis of familial papillary thyroid carcinoma--a large-scale, matched, case-control study.

Cao J, Chen C, Chen C, Wang QL, Ge MH.

Clin Endocrinol (Oxf). 2016 Apr;84(4):598-606. doi: 10.1111/cen.12859. Epub 2015 Aug 11.

PMID:
26191611
18.

[Biological characteristics and management of familial papillary thyroid carcinoma].

Zhao J, Yu Y, Xia TT, Liu YZ, Wei SF, Zheng XQ, Gao M.

Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011 Nov;46(11):897-900. Chinese.

PMID:
22335974
19.

[Next generation sequencing technology for susceptible gene screening in familial non-medullary thyroid carcinoma].

Dong L, Yu Y, Yu JP, Hao WJ, Zheng XQ, Cheng YN, Han L, Zhao JZ, Gao M.

Zhonghua Zhong Liu Za Zhi. 2017 Jan 23;39(1):24-28. doi: 10.3760/cma.j.issn.0253-3766.2017.01.005. Chinese.

PMID:
28104029
20.

Familial non-medullary thyroid cancer: a matched-case control study.

Maxwell EL, Hall FT, Freeman JL.

Laryngoscope. 2004 Dec;114(12):2182-6.

PMID:
15564841

Supplemental Content

Support Center